Adrian Alegre

8PUBLICATIONS
99CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumoursGene and molecular therapyRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 22, 2024
Curative Strategy for High-Risk Smoldering Myeloma: Carfilzomib, Lenalidomide, and Dexamethasone (KRd) Followed by Transplant, KRd Consolidation, and Rd Maintenance.

María-Victoria Mateos, Joaquin Martínez-López, Paula Rodriguez Otero

|Jul 08, 2024
Biological relapse in multiple myeloma: Outcome and treatment strategies in a Spanish real-world setting.

Adrián Alegre, Mercedes Gironella, Fernando Escalante

|Jan 23, 2024
COVID-19 Outcomes in Patients with Hematologic Malignancies in the Era of COVID-19 Vaccination and the Omicron Variant.

Joaquín Martínez-López, Javier de la Cruz, Rodrigo Gil-Manso

|Jun 10, 2023
Belantamab Mafodotin in Patients with Relapsed/Refractory Multiple Myeloma: Results of the Compassionate Use or the Expanded Access Program in Spain.

Javier de la Rubia, Rafael Alonso, María Esther Clavero

|Mar 11, 2023
COVID-19 Severity and Survival over Time in Patients with Hematologic Malignancies: A Population-Based Registry Study.

Joaquín Martínez-López, Javier De la Cruz, Rodrigo Gil-Manso

|Sep 08, 2022
Circulating Tumor and Immune Cells for Minimally Invasive Risk Stratification of Smoldering Multiple Myeloma.

Rosalinda Termini, David Žihala, Evangelos Terpos

Pageof 2

Frequent Collaborators

5 joint publications

Joaquín Martínez-López

4 joint publications

Javier de la Rubia

3 joint publications

Javier López-Jiménez

3 joint publications

Albert Oriol